JOHN DEFOREST: Open Payments
NPI 1003842964 · BEECHER, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,762 in 90 payments from 19 companies in 2025. Trend: 2023 $1,318 · 2024 $1,661 · 2025 $1,762
Food & beverage: $1,762
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 21 | $474 |
| ABBVIE INC. | 9 | $245 |
| Lilly USA, LLC | 14 | $174 |
| Viatris Specialty LLC | 8 | $140 |
| Astellas Pharma US Inc | 7 | $133 |
| Amgen Inc. | 6 | $102 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $93 |
| Novo Nordisk Inc | 5 | $85 |
| Sumitomo Pharma America, Inc. | 3 | $69 |
| Otsuka America Pharmaceutical, Inc. | 2 | $39 |
Products named: FARXIGA, YUPELRI, AIRSUPRA, Veozah, QULIPTA, MOUNJARO, JARDIANCE, VRAYLAR.
Industry payments across IL — which companies pay providers there.
